Sarepta, Roche pause Elevidys trials in Europe following patient death
Sarepta and Roche are hitting the brakes on three trials of their Duchenne gene therapy Elevidys in response to a request by the European Medicines Agency. The drugmakers are pausing enrollment and dosing at all ...
Sarepta and Roche are hitting the brakes on three trials of their Duchenne gene therapy Elevidys in response to a request by the European Medicines Agency.
The drugmakers are pausing enrollment and dosing at all ...
